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Abstract
Background and Aims: The effect of red palm oil (RPO) supplementation on infarct size after ischaemia/
reperfusion in a cholesterol enriched diet-induced hyperlipidemic animal model has not been reported. Previous
studies reported results on the effect of RPO in a normal diet, whilst evidence of protection has been linked to
improved functional recovery, prosurvival kinase, anti-apoptosis and NO-cGMP. Therefore, we aimed to investigate
the effects of dietary RPO supplementation in a cholesterol-enriched diet-induced hyperlipidemic rat model and to
investigate the involvement of matrix metalloproteinase 2 (MMP2) inhibition as a possible mechanism of
protection.
Materials and Methods: Male Wistar rats were fed either a standard rat chow diet (Norm) or a 2% cholesterol-
enriched diet (Chol) for nine weeks. Additionally, two more groups received the same treatment, however, at the
week 4, diet was supplemented with RPO for the last five weeks (Norm+RPO and Chol+RPO), respectively. After
the feeding period hearts were isolated, perfused according to Langendorff and subjected to 30 minutes of
normothermic global ischaemia followed by two hours of reperfusion. Infarct size was measured by 2,3,5-
triphenyltetrazolium chloride staining at the end of reperfusion.
Results: Cholesterol-enriched diet increased myocardial infarct size from 23.5 ± 3.0% to 37.2 ± 3.6% (p < 0.05)
when compared to normal diet. RPO supplementation significantly reduced infarct size either in Norm+RPO or in
Chol+RPO (to 9.2 ± 1.0% and 26.9 ± 3.0%), respectively. Infarct size in Chol+RPO was comparable to the Norm
group. MMP2 activity before ischaemia was significantly reduced in the Chol+RPO group when compared to the
Chol group. However, the MMP2 activity of the hearts of the RPO fed rats was significantly increased when
compared to the normal diet group after ischaemia.
Conclusions: For the first time it was shown that dietary RPO supplementation attenuated the increased
susceptibility of the hearts in cholesterol fed rats to ischaemia/reperfusion injury. This was shown by reduced
infarct size. For the first time we also show that red palm oil supplementation altered pre-ischaemic levels of MMP-
2, which may indicate that myocardial MMP2 may be implicated as a possible role player in RPO mediated
protection against ischaemia/reperfusion injury in hearts of cholesterol supplemented rats.
Introduction
Many cardiovascular ischaemia/reperfusion injury studies
use healthy rats for their research protocols. In clinical
conditions, unhealthy diets and lifestyle are normally asso-
ciated with increased risk of myocardial infarction [1].
Previous studies using healthy animals contributed to elu-
cidating certain mechanisms of cardiovascular protection.
However, it has recently been shown that cholesterol feed-
ing reverses the beneficial effects of preconditioning [2].
One such a model is a mildly dislipidaemic rat model,
where the rat is supplemented with low doses of choles-
terol for a short time period. In this model, peroxynitrite
was increased with a subsequent reduction of myocardial
function [3]. This ultimately led to contractile failure
of the myocardium, or myocardial stunning injury.
Additionally, this model was shown to inhibit the
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Osipov and co-workers (2009) demonstrated in an in vivo
hypercholesterolaemic pig model increased infarct size
when compared with normal control animals [4]. The
authors concluded that increased infarct size in hypercho-
lesterolaemic hearts was associated with increased oxida-
tive stress and inflammation, together with
downregulation of cell survival pathways and induction of
apoptosis.
Red palm oil (RPO) is an antioxidant rich oil which
contains approximately 50% saturated and 50% unsatu-
rated fatty acids [5,6]. Carotenoids and vitamin E (75%
of which is tocotrienol) are the most abundant antioxi-
dants in this oil. Both of these antioxidants are con-
tained at a level of at least 500 ppm in RPO [5,6]. The
cocktail of antioxidants within RPO is believed to have
synergistic effects [7,8]. The oil offers cardioprotection,
by activation of several different protective pathways
which work synergistically together [9].
Dietary RPO supplementation has previously been
shown to offer protection against ischaemia/reperfusion
injury in the isolated perfused heart [10-12]. Esterhuyse
and co-workers (2005) [10] showed that dietary RPO sup-
plementation could improve post ischaemic functional
recovery in rats fed a standard rat chow diet (SRC), and
rats fed a SRC plus 2% cholesterol for six weeks [10]. They
suggested that RPO mediated protection against ischae-
mia/reperfusion injury may be induced through different
pathways in hearts of SRC fed and cholesterol fed rats.
Matrix metalloproteinases (MMPs) are calcium and zinc
dependent endopeptidases. Under normal physiological
conditions they facilitate cell migration and tissue remo-
deling [13]. Recently it was found that MMP2 plays a role
in ischaemia/reperfusion damage in the heart [14].
Increased MMP2 activity has also been associated with
hypercholesterolaemic diets [2]. This may be due to the
increased peroxynitrite production within the myocardium
[3]. ROS, and peroxynitrite have been shown to activate
MMP2 through redox modification of the regulatory site
of this enzyme [15-18]. This redox modification leads to
activity being displayed in the 75 and 72 kDa isoforms of
the enzyme, while only the 64 kDa isoform is active if
MMP2 is activated in the classical manner [16,18]. Acti-
vated MMP2 damages cardiomyocytes during reperfusion.
This is achieved by cleaving the contractile protein regula-
tory element, troponin I and possibly other structural and
cytoskeletal proteins [19-24]. Activation of MMP2 during
an ischaemic insult is therefore normally associated with
decreased functional recovery and larger infarct size of the
heart [14,25-28]. This has been confirmed through inhibi-
tion of MMP2 by antibodies or chemical agents [29-33].
In a recent study [34] it was shown that red palm oil
reduced infarct size in a model of ischaemia/reperfusion
injury. However, this model investigated only healthy
hearts. The intention of the current study was therefore
to use a high cholesterol feeding model to ensure that
the model is more clinically relevant and to establish
confirmation that red palm oil protection are indeed
applicable in unhealthy diets, as was previously argued.
In all red palm oil fed studies up to date [9-12], results
have indicated post-ischaemic involvement of certain
cellular biochemical pathways. However, none of these
studies provided any evidence of pre-ischaemic protec-
tion by red palm oil.
The aims of this study were: 1) to investigate the
effects of dietary RPO supplementation on myocardial
infarct size in the hearts of rats on a cholesterol-
enriched diet and 2) to determine whether MMP2 activ-
ity was altered by RPO supplementation, both pre- and
post-ischaemically.
Materials and Methods
All rats received humane animal care in accordance with
the Guide for the Care and Use of Laboratory Animals,
published by the United States National Institutes of
Health (NIH publication 8523, revised 1985).
Experimental design
Male Wistar rats were divided into four groups. Rats in
these groups were placed on the following diets,
respectively:
Group 1: Standard rat chow diet for 9 weeks (Norm)
Group 2: 2% cholesterol-enriched diet for 9 weeks
(Chol)
Group 3: Standard rat chow supplemented with 200 μl
RPO (Norm+RPO) per day for the last 5 weeks of the 9
week period
Group 4: 2% cholesterol-enriched diet for nine weeks
supplemented with 200 μl RPO per day for the last 5
weeks of the 9 week period (Chol+RPO)
Rats were individually housed to ensure that each animal
received equal amounts of supplements. RPO and supple-
ments were prepared on a daily basis in order to prevent
spoiling. Rats were allowed ad libitum access to food and
water.
Isolated heart perfusion
After the feeding period, rats were anaesthetized using
diethyl ether. Hearts were isolated, mounted on a Lan-
gendorff perfusion apparatus, and were perfused at 37°C
using a Krebs-Henseleit buffer solution which was con-
stantly gassed with 5% carbon dioxide, 95% oxygen and a
constant perfusion pressure of 100 cmH20w a sm a i n -
tained. After mounting, hearts were subjected to 10 min-
utes of stabilization, followed by 30 minutes of
normothermic global ischaemia and 120 minutes of
reperfusion. At the end of the perfusion protocol ventri-
cular tissue was frozen at -20°C overnight.
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Frozen hearts were cut into 2 mm thick cross-sectional
slices. These slices were stained in 2,3,5-triphenyltetra-
zolium chloride (TTC) for 10 minutes at 37°C. After
TTC staining, the slices were transferred to a formalin
solution for ten minutes and then placed in phosphate
buffer (pH 7.4) [35,36]. Heart slices were then placed
between two sheets of glass and scanned into a compu-
ter and analyzed using infarct size planimetry software
(Infarctsize™ 1.0 Pharmahungary, Szeged, Hungary) in a
blinded manner. Infarct size was represented as percen-
tage of the area at risk.
MMP2 zymography
Coronary effluent collected for 10 minutes before
ischaemia and the first 10 minutes of reperfusion was
concentrated by ultra filtration using Amicon ultra fil-
tration tubes. The concentrated coronary flow was then
subjected to gelatin zymography.
Gelatinolytic activities of MMPs were examined as
previously described [18]. Briefly, polyacrylamide gels
were copolymerized with gelatin, and a constant amount
of protein was separated by electrophoresis in each lane.
Following electrophoresis, gels were washed with 2.5%
Triton X-100 and incubated for 20 hours at 37°C in
incubation buffer. Gels were then stained with 0.05%
Coomassie Brilliant Blue in a mixture of methanol/acetic
acid/water and destained in aqueous 4% methanol/8%
acetic acid. Zymograms were digitally scanned, and
band intensities were quantified using Quantity One
software (Bio-Rad, Hercules, CA) and expressed as a
ratio to the internal standard.
Serum cholesterol and triglyceride measurement
Serum cholesterol and triglyceride were measured using a
test kit supplied by Diagnosticum Zrt. (Budapest, Hun-
gary) as described previously [37].
Statistics
All values are presented as mean ± SEM. Differences
among means were analyzed by two-way ANOVA fol-
lowed by an appropriate post hoc test to make all pair-
wise comparisons and comparisons of each group to the
respective control. P was considered significant if it was
less than 0.05.
Results
Animal mass
The body and heart weight of the RPO supplemented
rats were significantly decreased when compared to the
Norm group and also to the Chol+RPO group after the
feeding period (Table 1).
Perfusion data
There were no significant differences in the coronary
effluent of any of the groups after the supplementation
period. Coronary effluent of all groups except the RPO
group was significantly decreased after ischaemia, when
compared to their baseline values. There were no signif-
icant differences in the heart rates before or after ischae-
mia (Table 2).
Infarct size
Cholesterol-enriched diet alone increased myocardial
infarct size from 23.5 ± 3.0% to 37.2 ± 3.6% (p < 0.05)
when compared to normal diet. RPO supplementation
significantly reduced infarct size in Norm+RPO and also
in Chol+RPO (9.2 ± 1.0% and 26.9 ± 3.0%), respectively
(Figure 1). Infarct size in Chol+RPO group was compar-
able to the group fed with normal diet.
MMP2
Before ischaemia activity of the 75kDa isoform of
MMP2 was significantly lower in the Chol+RPO group
when compared to the Chol group (228 ± 28 arbitrary
units versus 450 ± 34 arbitrary units; Figure 2). After
ischaemia MMP2 (72kDa isoform) activity of the RPO
supplemented group was significantly increased when
compared to rats with normal diet (2472 ± 132 arbitrary
units versus 2007 ± 68 arbitrary units; Figure 3).
Serum lipid profile
There were no significant differences in the serum
total cholesterol and triglyceride level among groups
(Table 3).
Discussion
Our results show that dietary RPO supplementation
reversed the negative effects of cholesterol supplementa-
tion in the ischaemia/reperfusion rat heart model. Further-
more, dietary RPO supplementation reduced myocardial
infarct size in cholesterol supplemented rats. Previous stu-
dies have shown that dietary RPO supplementation
improved functional recovery of cholesterol fed rats after
ischaemia [10,12]. In the present study cholesterol supple-
mentation was carried out for a longer period (nine weeks
versus six weeks in previous studies). This indicates that
RPO could effectively protect hearts against ischaemia/
reperfusion injury, despite a longer duration of cholesterol
feeding. Osipov and co-workers (2009) found that
hypercholesterolaemic pigs had increased left ventricular
function throughout the ischaemia/reperfusion period
when compared to normal pigs [4]. This was, however,
associated with an increased infarct size and increased
apoptotic markers. Our results together with previous
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harmful effects of cholesterol supplementation in the
ischaemia/reperfusion model. Our total serum cholesterol
results were not increased in the cholesterol fed rats. This
was expected, as a previous study employed a similar
model of cholesterol feeding in rats, without achieving sig-
nificant changes in serum cholesterol [38]. The effects of
the cholesterol feeding on the cardiovascular system are
however clearly discussed in the study of Giricz and co-
workers (2003) through the depletion of nitric oxide, and
our current study by increased myocardial infarct size [38].
Coronary flow in the Norm group was reduced by
70%, in the Chol group by 64%, in the Chol+RPO group
by 57% and in the Norm+RPO group by 33% after
ischaemia. This indicates that RPO attenuated the fall in
coronary flow after ischaemia. This may suggest that
RPO supplementation improves vascular function during
reperfusion.
MMP2 activity was measured before ischaemia in the
cholesterol supplemented groups and compared to a
Norm control group and a RPO supplemented group, as it
may be expected that the cholesterol supplemented groups
may have increased oxidative stress after supplementation.
As increased oxidative stress leads to activation of MMP2
through redox modification of it’s regulatory subunit, this
would be associated with changes in MMP2 activity before
ischaemia which would be expected to be absent in nor-
mal rats [2,15-18]. Our results demonstrate for the first
time that dietary RPO supplementation may alter myocar-
dial oxidative stress before ischaemia in cholesterol fed
rats, as MMP2 activity was reduced before ischaemia. The
reduction in MMP2 activity before ischaemia in rats sup-
plemented with both cholesterol and RPO suggests that
RPO was able to reduce oxidative stress in these rats. This
would most probably be achieved through quenching of
ROS, which is generated in greater proportions in choles-
terol supplemented rats [3,38]. Increased generation of
ROS and oxidative stress would normally be associated
with activation of MMP2 [15,17,18]. As increased activity
of MMP2 may lead to either cardiac remodeling, or tissue
damage [21-24], this reduction in MMP2 activity may play
a role in RPO mediated protection against ischaemia/
reperfusion injury. However, MMP2 activity of the Norm
+RPO was increased during reperfusion, when compared
to normal rats without RPO supplementation. This would
normally be associated with increased myocardial suscept-
ibility to ischaemia/reperfusion injury [14,25-28]. RPO was
able to reduce myocardial infarct size in cholesterol fed
rats, despite increased activity of MMP2 in reperfusion
found in normal rats. This suggests MMP2 activity may
only play a protective role in cholesterol fed rats, and that
other protective pathways are responsible for RPO
mediated protection in normal rats.
The aim of this study was to investigate whether
MMP2 activity was involved in RPO mediated protection
of cholesterol fed rat hearts against ischaemia/reperfu-
sion. Our results suggest that MMP2 activity may play a
role in RPO mediated protection of the hearts of the cho-
lesterol fed rats, but not the hearts of SRC fed rats. This
suggests that more pathways of protection may play a
role in this protection. Kruger and co-workers (2007)
[12] found that RPO supplementation of cholesterol fed
rats led to decreased phosphorylation of pro-apoptotic
molecules, p38 and JNK. This coincided with increased
phosphorylation of the pro-survival kinase ERK early in
reperfusion, which leads to reduced apoptosis. Apoptosis
has been shown to play a role in the detrimental effects
of hypercholesterolaemia in the heart. Inhibition of apop-
tosis may therefore explain the protective effects of RPO
in this model [12].
Conclusion
For the first time we showed that dietary RPO supple-
mentation attenuated increased susceptibility of choles-
terol fed rat hearts to ischaemia/reperfusion injury as
evidenced by reduced infarct size. Myocardial MMP2
Table 2 Coronary effluent (CE) collected for 10 min to measure MMP activity and heart rate (HR) before and after
ischaemia
CE before ischaemia (mL/10 min) CE after ischaemia (mL/10 min) HR before ischaemia (BPM) HR after ischaemia (BPM)
Norm 205.0 ± 5.7 59.2 ± 4.0* 387.4 ± 56.5 338.0 ± 128.6
Chol 185.9 ± 21.7 67.1 ± 6.5* 390.8 ± 37.3 346.0 ± 115.3
Norm+RPO 152.5 ± 12.9 100.0 ± 6.9 344.1 ± 12.0 328.0 ± 40.7
Chol+RPO 141.9 ± 12.5 61.9 ± 3.8* 327.3 ± 17.6 339.0 ± 29.2
Values are mean ± SEM, n = 8; *p < 0.05 versus the corresponding “before ischaemia” values.
Table 1 Animal mass and heart mass after a nine week diet
Norm Chol Norm+RPO Chol+RPO
Animal mass (g) 494.0 ± 18.1 472.6 ± 13.5 381.3 ± 7.6* 511.5 ± 14.4
Heart mass (g) 1.6 ± 0.1 1.7 ± 0.1 1.4 ± 0.1* 1.7 ± 0.1
Values are mean ± SEM, n = 8; *p < 0.05 versus Norm and Chol+RPO
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ted rat hearts before ischaemia (Figure 2), but not after
ischaemia (Figure 3) associated with decreased infarct
size. This may suggest a different or additional mechan-
ism of protection.
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Figure 1 Myocardial infarct size in rats fed different diets for
nine weeks. Infarct size is expressed as a percentage of the area at
risk, values are mean ± SEM, n = 8; *p < 0.05 versus corresponding
non-RPO treated groups; #p < 0.05 versus corresponding normal diet.
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Figure 2 MMP2 activity in coronary effluent collected for 10
minutes before ischaemia. Values are mean ± SEM, n = 8; *p <
0.05 versus corresponding non-RPO treated groups; #p < 0.05 versus
corresponding normal diet.
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Figure 3 MMP2 activity in coronary effluent collected for the first
10 minutes of reperfusion. Values are mean ± SEM, n = 8; *p < 0.05
versus corresponding non-RPO treated groups; #p < 0.05 versus
corresponding normal diet.
Table 3 Serum total cholesterol and serum triglyceride
levels of rats after nine weeks of diet
Norm Chol Norm+RPO Chol+RPO
Total cholesterol
(mmol/L)
1.96 ± 0.05 1.91 ± 0.05 2.15 ± 0.23 1.79 ± 0.04
Triglycerides
(mmol/L)
0.72 ± 0.06 0.80 ± 0.08 0.71 ± 0.06 0.80 ± 0.07
Values are mean ± SEM, n = 8.
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